Literature DB >> 7103798

Metoclopramide-induced Parkinsonism. Clinical characteristics of ten cases.

T Indo, K Ando.   

Abstract

Clinical characteristics of ten patients with metoclopramide hydrochloride-induced parkinsonism were studied. This condition was found to be more common in aged women and developed subacutely with bilateral symptoms. Clinically, metoclopramide-induced parkinsonism is sometimes accompanied by a rest tremor and may therefore be confused with Parkinson's disease. It is distinct from the latter in that orolingual dyskinesia and postural tremor are often found before the administration of antiparkinsonian drugs. The patients with metoclopramide-induced parkinsonism made a complete recovery within a few months after administration of the drug was discontinued.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7103798     DOI: 10.1001/archneur.1982.00510200036006

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  17 in total

1.  Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors.

Authors:  A Hamik; S J Peroutka
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 2.  Gastrointestinal motility problems in patients with Parkinson's disease. Effects of antiparkinsonian treatment and guidelines for management.

Authors:  W H Jost
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

3.  Extrapyramidal and depressive side reactions with flunarizine and cinarizine.

Authors:  C A Mangone; E Herskovits
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

4.  High exposure compared with standard exposure to metoclopramide associated with a higher risk of parkinsonism: a nationwide population-based cohort study.

Authors:  Shin-Chia Tsai; Shiow-Yunn Sheu; Li-Nien Chien; Hsin-Chien Lee; Eunice Jia-Shiow Yuan; Rey-Yue Yuan
Journal:  Br J Clin Pharmacol       Date:  2018-06-19       Impact factor: 4.335

5.  Metoclopramide and tardive dyskinesia in the elderly.

Authors:  M L Orme; R C Tallis
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-18

6.  Neuroleptic malignant syndrome associated with metoclopramide.

Authors:  M B Robinson; R P Kennett; A E Harding; N J Legg; B Clarke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

7.  Antiparkinsonian Agents : Clinically Significant Drug Interactions and Adverse Effects, and Their Management.

Authors:  A Dalvi; B Ford
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

Review 8.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

9.  A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.

Authors:  N Quinn; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

Review 10.  Physical assessment and differential diagnosis of the poisoned patient.

Authors:  K R Olson; P R Pentel; M T Kelley
Journal:  Med Toxicol       Date:  1987 Jan-Feb
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.